Armata Pharmaceuticals ARMP Stock
Armata Pharmaceuticals Price Chart
Armata Pharmaceuticals ARMP Financial and Trading Overview
| Armata Pharmaceuticals stock price | 3.87 USD |
| Previous Close | 3.72 USD |
| Open | 3.85 USD |
| Bid | 3.61 USD x 40000 |
| Ask | 3.94 USD x 10000 |
| Day's Range | 3.87 - 3.87 USD |
| 52 Week Range | 2.75 - 14.98 USD |
| Volume | 1.07K USD |
| Avg. Volume | 181.91K USD |
| Market Cap | 143.15M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.29 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.5 USD |
ARMP Valuation Measures
| Enterprise Value | 366.92M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8872548 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.9478 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 48.567 |
| Enterprise Value/EBITDA | -11.169 |
Trading Information
Armata Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -49.18% |
| S&P500 52-Week Change | 12.74% |
| 52 Week High | 14.98 USD |
| 52 Week Low | 2.75 USD |
| 50-Day Moving Average | 3.83 USD |
| 200-Day Moving Average | 6.89 USD |
ARMP Share Statistics
| Avg. Volume (3 month) | 181.91K USD |
| Avg. Daily Volume (10-Days) | 67.68K USD |
| Shares Outstanding | 37.18M |
| Float | 11.9M |
| Short Ratio | 9.08 |
| % Held by Insiders | 67.63% |
| % Held by Institutions | 13.92% |
| Shares Short | 912.61K |
| Short % of Float | 8.10% |
| Short % of Shares Outstanding | 2.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -461.82% |
| Gross Margin | -108.033% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.065% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 7.56M USD |
| Revenue Per Share (ttm) | 0.21 USD |
| Quarterly Revenue Growth (yoy) | 173.59% |
| Gross Profit (ttm) | -8162000 USD |
| EBITDA | -32853000 USD |
| Net Income Avi to Common (ttm) | -113710000 USD |
| Diluted EPS (ttm) | -5.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.32M USD |
| Total Cash Per Share (mrq) | 0.49 USD |
| Total Debt (mrq) | 246.92M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.121 |
| Book Value Per Share (mrq) | -4.683 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26638000 USD |
| Levered Free Cash Flow (ttm) | -30595376 USD |
Profile of Armata Pharmaceuticals
| Country | United States |
| State | CA |
| City | Los Angeles |
| Address | 5005 McConnell Avenue |
| ZIP | 90066 |
| Phone | 310 665 2928 |
| Website | https://www.armatapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 61 |
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Q&A For Armata Pharmaceuticals Stock
What is a current ARMP stock price?
Armata Pharmaceuticals ARMP stock price today per share is 3.87 USD.
How to purchase Armata Pharmaceuticals stock?
You can buy ARMP shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Armata Pharmaceuticals?
The stock symbol or ticker of Armata Pharmaceuticals is ARMP.
Which industry does the Armata Pharmaceuticals company belong to?
The Armata Pharmaceuticals industry is Biotechnology.
How many shares does Armata Pharmaceuticals have in circulation?
The max supply of Armata Pharmaceuticals shares is 37.18M.
What is Armata Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Armata Pharmaceuticals PE Ratio is now.
What was Armata Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Armata Pharmaceuticals EPS is -5.29 USD over the trailing 12 months.
Which sector does the Armata Pharmaceuticals company belong to?
The Armata Pharmaceuticals sector is Healthcare.
